Overall market sentiment has been down on CEL-SCI Corporation (CVM) stock lately. CVM receives a Bearish rating from InvestorsObserver's Stock Sentiment Indicator.
What is Stock Sentiment?
Sentiment is a very short-term indicator that is entirely technical. There is no information about the health of profitability of the underlying company in our sentiment score.
As a technical indicator, news about the stock, or company, such as an earnings release or other event, could move the stock counter to the recent trend.
Sentiment is how investors, or the market, feels about a stock. There are lots of ways to measure sentiment. At the core, sentiment is pretty easy to understand. If a stock is going up, investors must be bullish, while if it is going down, sentiment is bearish.
InvestorsObserver’s Sentiment Indicator looks at price trends over the past week and also considers changes in volume. Increasing volume can mean a trend is getting stronger, while decreasing volume can mean a trend is nearing a conclusion.
For stocks that have options, our system also considers the balance between calls, which are often bets that the price will go up, and puts, which are frequently bets that the price will fall.
What's Happening With CVM Stock Today?
CEL-SCI Corporation (CVM) stock is down -10.13% while the S&P 500 is higher by 0.06% as of 9:47 AM on Wednesday, Jun 30. CVM is down -$1.30 from the previous closing price of $12.83 on volume of 477,492 shares. Over the past year the S&P 500 is higher by 40.64% while CVM is down -26.70%. CVM lost -$0.91 per share in the over the last 12 months.
To screen for more stocks like CEL-SCI Corporation click here.
More About CEL-SCI Corporation
CEL-SCI Corp is a player in the biotechnology sector. It is engaged in the research and development at developing the treatment of cancer and other diseases by using the immune system. The company is focused on activating the immune system to fight cancer and infectious diseases. It is focused on the development of Multikine (Leukocyte Interleukin, Injection), investigational immunotherapy under development for the treatment of certain head and neck cancers, and anal warts or cervical dysplasia.
Click Here to get the full Stock Score Report on CEL-SCI Corporation (CVM) Stock.
